Literature DB >> 29296806

BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Karen A Dun1, Rob Vanhaeften2, Tracey J Batt3, Louise A Riley1, Giuseppe Diano1, Jan Williamson2.   

Abstract

We report here on a case of ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia (B-ALL) that has acquired a BCR-ABL1 gene rearrangement as a subclonal change. The 19-year-old female patient presented with B symptoms, pancytopenia, and circulating blasts. The bone marrow aspirate was hypercellular and was infiltrated by an immature blast population that was confirmed as B-ALL by flow cytometry. Sequential fluorescent in situ hybridization was performed on the patient's leukemic cells, which were shown to contain both ETV6-RUNX1 and BCR-ABL1 gene rearrangements. The majority of nuclei (85%) showed only the ETV6-RUNX1 gene rearrangement; however, an additional 10% also showed a variant BCR-ABL1 gene rearrangement, indicating the ETV6-RUNX1 gene rearrangement was the primary change. A review of the literature has shown that acquisition of a BCR-ABL1 gene rearrangement as a secondary change in B-ALL is a very rare occurrence, and the effect it may have on prognosis is uncertain in the modern therapy age.

Entities:  

Year:  2016        PMID: 29296806      PMCID: PMC5737165          DOI: 10.1182/bloodadvances.2016000463

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  29 in total

1.  Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.

Authors:  Ulrike Bacher; Torsten Haferlach; Tamara Alpermann; Melanie Zenger; Andreas Hochhaus; Dietrich W Beelen; Michael Uppenkamp; Mathias Rummel; Wolfgang Kern; Susanne Schnittger; Claudia Haferlach
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

2.  Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia.

Authors:  Louise Borst; Agata Wesolowska; Tejal Joshi; Rehannah Borup; Finn C Nielsen; Mette K Andersen; Olafur G Jonsson; Peder S Wehner; Finn Wesenberg; Britt-Marie Frost; Ramneek Gupta; Kjeld Schmiegelow
Journal:  Br J Haematol       Date:  2012-03-07       Impact factor: 6.998

3.  Refining prognosis in BCR-ABL1-positive ALL.

Authors:  Elizabeth A Raetz; William L Carroll
Journal:  Blood       Date:  2014-03-13       Impact factor: 22.113

4.  Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics.

Authors:  S Branford; T P Hughes; Z Rudzki
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

5.  How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Adele K Fielding
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

6.  Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia.

Authors:  S D Raynaud; N Dastugue; D Zoccola; S A Shurtleff; S Mathew; S C Raimondi
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

7.  Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.

Authors:  K Suryanarayan; S P Hunger; S Kohler; A J Carroll; W Crist; M P Link; M L Cleary
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

8.  Ph1-positive and Ph1-negative abnormal cell lines in a child with lymphoblastic lymphoma.

Authors:  T Shikano; Y Kaneko; Y Ishikawa; N Niikawa; T Tono-oka; T Takeda; M Kikuchi
Journal:  Br J Haematol       Date:  1984-11       Impact factor: 6.998

9.  Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region.

Authors:  H Lilljebjörn; M Heidenblad; B Nilsson; C Lassen; A Horvat; J Heldrup; M Behrendtz; B Johansson; A Andersson; T Fioretos
Journal:  Leukemia       Date:  2007-08-09       Impact factor: 11.528

10.  FISH mapping of Philadelphia negative BCR/ABL1 positive CML.

Authors:  Anna Virgili; Diana Brazma; Alistair G Reid; Julie Howard-Reeves; Mikel Valgañón; Anastasios Chanalaris; Valeria As De Melo; David Marin; Jane F Apperley; Colin Grace; Ellie P Nacheva
Journal:  Mol Cytogenet       Date:  2008-07-18       Impact factor: 2.009

View more
  2 in total

1.  [Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds].

Authors:  Tong Wei; Xiao-Juan Chen; Lu-Yang Zhang; Ao-Li Zhang; Xiao-Fan Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-12

2.  CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.

Authors:  Dafné Moreno Lorenzana; María Del Rocío Juárez Velázquez; Adriana Reyes León; Daniel Martínez Anaya; Adrián Hernández Monterde; Consuelo Salas Labadía; María Del Pilar Navarrete Meneses; Marta Zapata Tarrés; Luis Juárez Villegas; Berenice Jarquín Ramírez; Rocío Cárdenas Cardós; Martha Herrera Almanza; Rogelio Paredes Aguilera; Patricia Pérez Vera
Journal:  J Pathol Clin Res       Date:  2021-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.